Latest filing published 14 May 2013 for Trius Therapeutics Inc.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
KPCB Pandemic & Bio Defense Fund LLC: trading record in brief
KPCB Pandemic & Bio Defense Fund LLC discloses dealings in Trius Therapeutics Inc to SEC (Form 4). In total, 4 filings cover trades dated from 6 August 2010 to 10 May 2013.
On the market, this insider has only ever bought: 1 purchase, €3.1M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 14 May 2013 came the latest disclosure, a transaction in Trius Therapeutics Inc. The most recent open-market purchase was published on 10 August 2010, 5,935 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to KPCB Pandemic & Bio Defense Fund LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 680,850 shares0Common StockSEC:0001181431-13-027528:0
- 1,055,581 sharesCommon StockSEC:0001104659-10-043319:0
- 498,394 sharesCommon StockSEC:0001104659-10-043319:1
- 823,906 shares@ US$5.00Common StockSEC:0001104659-10-043319:2Canonical exit: 4 Nov 2010 (T+90)
4 of 4 declarations
